##gff-version 3
##sequence-region Q8TD08 1 544
Q8TD08	UniProtKB	Chain	1	544	.	.	.	ID=PRO_0000232637;Note=Mitogen-activated protein kinase 15	
Q8TD08	UniProtKB	Domain	13	304	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q8TD08	UniProtKB	Repeat	371	375	.	.	.	Note=PXXXP motif;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Repeat	378	382	.	.	.	Note=PXXXP motif;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Repeat	386	390	.	.	.	Note=PXXXP motif%3B regulates binding with chromatin and interaction with PCNA;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Repeat	394	398	.	.	.	Note=PXXXP motif%3B regulates binding with chromatin and interaction with PCNA;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Nucleotide binding	19	27	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q8TD08	UniProtKB	Region	265	285	.	.	.	Note=Necessary to interact with ESRRA%2C to regulate its subcellular localization and to inhibit its transcriptional activity;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21190936;Dbxref=PMID:21190936	
Q8TD08	UniProtKB	Region	300	373	.	.	.	Note=Requires for interaction with GABARAP%2C MAP1LC3B AND GABARAPL1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22948227;Dbxref=PMID:22948227	
Q8TD08	UniProtKB	Motif	175	177	.	.	.	Note=TXY	
Q8TD08	UniProtKB	Active site	137	137	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q8TD08	UniProtKB	Binding site	42	42	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q8TD08	UniProtKB	Modified residue	175	175	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11875070,ECO:0000269|PubMed:16336213,ECO:0000269|PubMed:19166846;Dbxref=PMID:11875070,PMID:16336213,PMID:19166846	
Q8TD08	UniProtKB	Modified residue	177	177	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11875070,ECO:0000269|PubMed:16336213,ECO:0000269|PubMed:19166846;Dbxref=PMID:11875070,PMID:16336213,PMID:19166846	
Q8TD08	UniProtKB	Modified residue	449	449	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24129315;Dbxref=PMID:24129315	
Q8TD08	UniProtKB	Alternative sequence	95	95	.	.	.	ID=VSP_017918;Note=In isoform 3. M->MGCPPSPPPPTAVRTLSA;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8TD08	UniProtKB	Alternative sequence	241	254	.	.	.	ID=VSP_017919;Note=In isoform 2. DLLALGSGCRASVL->GAQTACRSGTGAST;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16484222;Dbxref=PMID:16484222	
Q8TD08	UniProtKB	Alternative sequence	255	544	.	.	.	ID=VSP_017920;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16484222;Dbxref=PMID:16484222	
Q8TD08	UniProtKB	Alternative sequence	261	544	.	.	.	ID=VSP_017921;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q8TD08	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_061535;Note=T->K;Dbxref=dbSNP:rs60732298	
Q8TD08	UniProtKB	Natural variant	505	505	.	.	.	ID=VAR_061536;Note=S->P;Dbxref=dbSNP:rs56038219	
Q8TD08	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Not phosphorylated at Thr-175 and Tyr-177. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16336213;Dbxref=PMID:16336213	
Q8TD08	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Loss of autophosphorylation and activity. Does not increase dopamine transporter activity. Impairs kinase activity. Does not rescue cilium assembly in MAPK15-depleted cells. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11875070,ECO:0000269|PubMed:28842414,ECO:0000269|PubMed:29021280;Dbxref=PMID:11875070,PMID:28842414,PMID:29021280	
Q8TD08	UniProtKB	Mutagenesis	59	59	.	.	.	Note=Does not increase dopamine transporter activity. Impairs kinase activity. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28842414;Dbxref=PMID:28842414	
Q8TD08	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Unable to induce the formation of autophagosomal structures. Is able to bind to MAP1LC3B and to colocalize with this protein to autophagosomal structures. Does not induce phosphorylation by methyl methanesulfonate. Loas of phosphorylation. Dominant negative mutant. Not phosphorylated at Thr-175 and Tyr-177. D->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16336213,ECO:0000269|PubMed:19166846,ECO:0000269|PubMed:22948227;Dbxref=PMID:16336213,PMID:19166846,PMID:22948227	
Q8TD08	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Loss of autophosphorylation and activity. Still heavily phosphorylated at Tyr-177. Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells%3B when associated with F-177. T->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11875070,ECO:0000269|PubMed:16336213,ECO:0000269|PubMed:24618899;Dbxref=PMID:11875070,PMID:16336213,PMID:24618899	
Q8TD08	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Loss of autophosphorylation and activity. Heavily phosphorylated at Thr-175. Y->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11875070,ECO:0000269|PubMed:16336213;Dbxref=PMID:11875070,PMID:16336213	
Q8TD08	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells%3B when associated with A-175. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24618899;Dbxref=PMID:24618899	
Q8TD08	UniProtKB	Mutagenesis	265	269	.	.	.	Note=Markedly decreases interaction with ESRRA. Impairs interaction with ESRRA%3B when associated with A-281 and 284-A--A-285. Loses the ability to re-localize ESRRA to the cytoplasm. Does not affect subcellular location in cytoplasm in presence of ESRRA. Loses the ability to repress ESRRA transcriptional activity. LDALL->ADAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21190936;Dbxref=PMID:21190936	
Q8TD08	UniProtKB	Mutagenesis	281	285	.	.	.	Note=Markedly decreases interaction with ESRRA. Impairs interaction with ESRRA%3B when associated with A-265 and 268-A--A-269. Loses the ability to re-localize ESRRA to the cytoplasm. Does not affect subcellular location in cytoplasm in presence of ESRRA.Loses the ability to repress ESRRA transcriptional activity. LRRLL->ARRAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21190936;Dbxref=PMID:21190936	
Q8TD08	UniProtKB	Mutagenesis	300	300	.	.	.	Note=Impairs interaction with PCNA. Associates with chromatin. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Mutagenesis	340	343	.	.	.	Note=Impairs interaction with GABARAP and MAP1LC3B. Affects subcellular localization in autophagosome. Does not induce autophagy. YQMI->AQMA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22948227;Dbxref=PMID:22948227	
Q8TD08	UniProtKB	Mutagenesis	390	390	.	.	.	Note=Impairs chromatin binding%3B when associated with A-398. Increases kinase activity%3B when associated with A-398. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Mutagenesis	398	398	.	.	.	Note=Impairs chromatin binding%3B when associated with A-390. Increases kinase activity%3B when associated with A-390. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20733054;Dbxref=PMID:20733054	
Q8TD08	UniProtKB	Sequence conflict	113	113	.	.	.	Note=H->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
